1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Lacosamide
Trade Name:
Vimpat
Manufacturer/Distributor:
UCB Canada Inc
www.ucb.com/worldwide/canada; 905-287-5129
Classification:
Anticonvulsant
ATC Class:
N03AX19 - Lacosamide
Status:
active
Notice of Compliance (yyyy/mm/dd):
2010/09/30
Date Marketed in Canada (yyyy/mm/dd):
2010/10/21
Presentation:
Tablet: 50 mg. DIN: 02357615
Tablet: 100 mg. DIN: 02357623
Tablet: 150 mg. DIN: 02357631
Tablet: 200 mg. DIN: 02357658
Injection: 10 mg/mL. DIN: 02357666
Comments:
Adjunctive agent used for the management of partial-onset seizures in adult patient who are not controlled with conventional therapy.
Back to:
Drug Product Listings 
